STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

[144] Aemetis, Inc. (DE) SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
144
Rhea-AI Filing Summary

A Form 144 notice shows a proposed sale of 26,452 shares of common stock of the issuer via Raymond James & Associates on 08/14/2025, with an aggregate market value of $66,923.56. The shares reported for sale were granted as restricted stock units (RSUs) by the issuer on 01/07/2021 (1,300 shares), 04/08/2021 (12,152 shares), 11/18/2021 (5,000 shares), and 08/18/2022 (8,000 shares). The filer reports no securities sold during the past 3 months and indicates payment for these proposed sales will be cash. The filing includes the standard representation that the seller does not possess undisclosed material information about the issuer.

Positive
  • None.
Negative
  • None.

Insights

TL;DR: Insider intends to sell 26,452 RSU-derived shares on 08/14/2025 through Raymond James; value disclosed is $66,923.56.

The filing is a routine Rule 144 notice documenting a proposed sale of shares that were acquired as RSUs on specific dates in 2021 and 2022. The notice provides the broker name, exact share counts by grant date, the aggregate market value, and confirms cash payment. There are no reported sales in the prior three months, which suggests this is an individual planned disposition rather than part of recent trading activity disclosed in the filing. The information is factual and limited to sale mechanics; it does not include any additional commentary on motive or company performance.

TL;DR: Form 144 accurately records a proposed sale of RSU-origin shares with full disclosure of acquisition dates and broker information.

The notice meets Rule 144 disclosure elements: class of security, broker, number of shares, aggregate value, acquisition details (RSU grants and dates), and sale timing. The filer affirms lack of undisclosed material information. No other governance-related actions or plan adoption dates are provided in the filing. As presented, this is a compliance-focused disclosure rather than a material governance event.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does the Form 144 for AMTX disclose about the proposed sale?

The filing discloses a proposed sale of 26,452 common shares via Raymond James on 08/14/2025 with aggregate market value of $66,923.56.

How were the shares being sold acquired according to the filing?

All reported shares were acquired as RSUs from the issuer on 01/07/2021 (1,300), 04/08/2021 (12,152), 11/18/2021 (5,000), and 08/18/2022 (8,000).

Does the Form 144 report any sales in the past three months for this filer?

The filing states "Nothing to Report" for securities sold during the past three months.

Who is the broker handling the proposed sale listed in the filing?

The broker named in the filing is Raymond James & Associates, located at 880 Carillon Parkway, St. Petersburg, FL.

What payment method is indicated for the proposed sale?

The filing indicates the sales are to be for cash.
Aemetis

NASDAQ:AMTX

AMTX Rankings

AMTX Latest News

AMTX Latest SEC Filings

AMTX Stock Data

125.89M
60.93M
7.33%
15.47%
7.35%
Specialty Chemicals
Industrial Organic Chemicals
Link
United States
CUPERTINO